GLASSIA
NDC 0944-2884, ALPHA.1-PROTEINASE INHIBITOR HUMAN, injection, solution, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 0944-2884
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125325
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2884 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- .ALPHA.1-PROTEINASE INHIBITOR HUMAN1 g/50mL
Pharmacologic classes
Human alpha-1 Proteinase Inhibitor [EPC]; Trypsin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0944-2884-01 | 00944288401 | 1 VIAL, GLASS in 1 CARTON (0944-2884-01) / 50 mL in 1 VIAL, GLASS (0944-2884-02) |
| 0944-2884-03 | 00944288403 | 1 VIAL, GLASS in 1 CARTON (0944-2884-03) / 200 mL in 1 VIAL, GLASS (0944-2884-04) |
| 0944-2884-05 | 00944288405 | 1 VIAL, GLASS in 1 CARTON (0944-2884-05) / 250 mL in 1 VIAL, GLASS (0944-2884-06) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0944-2884
Use it
Look up 0944-2884 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2884 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0944-2884. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.